Fingerprint
Dive into the research topics of 'Natalizumab: Benefit outweighs risk in selected patients with multiple sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Natalizumab: Benefit outweighs risk in selected patients with multiple sclerosis
J. Theodore Phillips, Elliot Frohman
Research output: Contribution to journal › Editorial › peer-review
1
Scopus
citations